Literature DB >> 1551045

Triiodothyronine potentiation of fluoxetine in depressed patients.

R T Joffe1.   

Abstract

Triiodothyronine (T3) has been shown to augment the therapeutic effect of tricyclic antidepressants as well as monoamine oxidase inhibitors. In this report, three cases of T3 potentiation of the antidepressant effect of fluoxetine are described. The results suggest that T3 augmentation may be effective with a wide range of antidepressants.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1551045     DOI： 10.1177/070674379203700111

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN： 0706-7437            Impact factor:   4.356


  3 in total

Review 1.  Pharmacological treatment of depression. Consulting with Dr Oscar.

Authors:  M J Berber
Journal:  Can Fam Physician       Date:  1999-11       Impact factor: 3.275

2.  An Evidence-Based Approach to Augmentation and Combination Strategies for: Treatment-Resistant Depression.

Authors:  Jeremy Barowsky; Thomas L Schwartz
Journal:  Psychiatry (Edgmont)       Date:  2006-07

Review 3.  Risk of adverse events with the use of augmentation therapy for the treatment of resistant depression.

Authors:  I Schweitzer; V Tuckwell
Journal:  Drug Saf       Date:  1998-12       Impact factor: 5.606
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.